About Us
Birdies Fore Logan is dedicated to improving outcomes for patients with rare lymphomas by addressing education, funding critical studies, and fostering collaborations to encourage in innovative therapies.
Mission
Birdies Fore Logan was created to raise awareness and funding for T-cell lymphoma research, while making a positive difference in the lives of those affected and championing innovative solutions in the fight against this deadly disease.
Vision
Our aim is to create a community where anyone affected can lean on us for help navigating a rare lymphoma diagnosis.
Join Us
Join us in honoring Logan’s life and continuing his fight. Together, we can transform the outlook for T-cell lymphoma patients and bring hope where it’s needed most. #ForeLogan
The Heart Behind Our Mission
Logan Goodson was a devoted husband, loving son, proud dog dad, and loyal friend whose warmth and humor left a lasting impression on everyone he met. He loved golf, good food, and UCF football, and he approached life with generosity and joy. That life was upended when Logan was diagnosed with ALK+ Anaplastic Large Cell Lymphoma (ALCL), a rare and aggressive cancer that disproportionately affects children and young adults.
​
Logan faced his diagnosis with resilience and hope. Initial treatments showed promise, but the disease returned and spread to his nervous system. With limited options available, his care team at MD Anderson pursued an innovative treatment using Alectinib, a drug typically prescribed for lung cancer. For a time, his symptoms improved and hope returned.
Ultimately, Logan needed a stem cell transplant, but a matching donor was never found. Even as the cancer progressed, Logan remained focused on others. In his final months, he told his wife and doctor, “We need better treatments. No one should have to go through this.” That wish became our mission.
​
Logan’s story is not just about one life, it’s about the urgent need for progress in T-cell lymphoma research. While B-cell lymphomas have seen major breakthroughs, T-cell lymphomas remain underfunded, understudied, and devastatingly hard to treat. Logan’s experience shines a light on this gap and calls us to action.
